The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
5 01 ACQUISITION CORP COM CL A 33836P105 3,596 365,126 SH   SOLE   365,126 0 0
AKOUOS INC COM 00973J101 35,154 4,135,784 SH   SOLE   4,135,784 0 0
ARVINAS INC COM 04335A105 32,856 400,000 SH   SOLE   400,000 0 0
AVIDITY BIOSCIENCES INC COM 05370A108 9,283 390,555 SH   SOLE   390,555 0 0
CABALETTA BIO INC COM 12674W109 7,824 2,064,263 SH   SOLE   2,064,263 0 0
CIDARA THERAPEUTICS INC COM 171757107 1,441 1,134,511 SH   SOLE   1,134,511 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107 24,498 862,286 SH   SOLE   862,286 0 0
ENTRADA THERAPEUTICS INC COM 29384C108 75,471 4,408,379 SH   SOLE   4,408,379 0 0
HOMOLOGY MEDICINES INC COM 438083107 16,511 4,535,919 SH   SOLE   4,535,919 0 0
IDEAYA BIOSCIENCES INC COM 45166A102 33,050 1,398,066 SH   SOLE   1,398,066 0 0
IMPEL NEUROPHARMA INC COM 45258K109 24,896 2,884,791 SH   SOLE   2,884,791 0 0
IVERIC BIO INC COM 46583P102 10,755 643,248 SH   SOLE   643,248 0 0
JANUX THERAPEUTICS INC COM 47103J105 8,805 446,266 SH   SOLE   446,266 0 0
PEAR THERAPEUTICS INC CLASS A COM 704723105 115,517 18,631,771 SH   SOLE   18,631,771 0 0
RALLYBIO CORP COM 75120L100 39,980 4,190,724 SH   SOLE   4,190,724 0 0
SCPHARMACEUTICALS INC COM 810648105 19,234 3,831,474 SH   SOLE   3,831,474 0 0
VOR BIOPHARMA INC COM 929033108 73,923 6,361,723 SH   SOLE   6,361,723 0 0